Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision v3.4.2 was added to the history, and a government funding notice along with the previous revision v3.4.1 were removed. These changes pertain to site-wide maintenance and do not alter the study data or record content.SummaryDifference0.7%

- Check12 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center status was added. The revision label was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check19 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights for additions (green) and deletions (red), along with an updated revision label (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check33 days agoChange DetectedVersion 13 adds the Contacts/Locations and Study Status sections to the record history. The update corresponds to Revision: v3.3.4 (2026-01-07).SummaryDifference0.6%

- Check54 days agoChange DetectedAdded a footer note 'Revision: v3.3.3'. Removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' note from the footer.SummaryDifference0.2%

- Check82 days agoChange DetectedThe history now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0, reflecting minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.